Hartmut Doehner
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 18
- Chronic Lymphocytic Leukemia Research 17
- Hematology 13
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- David HeadRoel WillemzeRichard A. LarsonJohn M. BennettBruce D. ChesonWolfgang HiddemannElihu H. EsteyFrancesco Lo‐Coco
- Journals
- Blood (22 papers)Haematologica (2 papers)Journal of Clinical Oncology (1 paper)Leukemia Research (1 paper)Leukemia (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Hartmut Doehner
30 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Hematology 1.9k
- Genetics 572
- Public Health, Environmental and Occupational Health 606
- Oncology 402
- Molecular Biology 806
Countries citing papers authored by Hartmut Doehner
This map shows the geographic impact of Hartmut Doehner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Doehner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Doehner more than expected).
Fields of papers citing papers by Hartmut Doehner
This network shows the impact of papers produced by Hartmut Doehner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Doehner. The network helps show where Hartmut Doehner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hartmut Doehner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 153 | |
| 2 | COMBINATION THERAPY OF POMALIDOMIDE PLUS RUXOLITINIB IN MYELOFIBROSIS: RESULTS FROM COHORT 1 OF THE MPNSG-0212 TRIAL (NCT01644110) | 2017 | 2 |
| 3 | 2015 | 9 | |
| 4 | THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI)-AN INTERNATIONAL META-ANALYSIS | 2015 | 6 |
| 5 | 2012 | 1 | |
| 6 | 2011 | 1 | |
| 7 | 2010 | 4 | |
| 8 | 2009 | 3 | |
| 9 | 2009 | 0 | |
| 10 | 2009 | 15 | |
| 11 | 2008 | 32 | |
| 12 | Imatinib plus hydroxyurea versus hydroxyurea monotherapy in progressive glioblastoma (GBM) - An international open label randomised phase III study (ambrosia-study) | 2007 | 2 |
| 13 | 2007 | 5 | |
| 14 | 2005 | 3 | |
| 15 | 2005 | 5 | |
| 16 | 2005 | 6 | |
| 17 | 2005 | 0 | |
| 18 | Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Hit paper breakdown → | 2003 | 1873 |
| 19 | Myeloablative radioimmunotherapy with Re-188-labeled anti-CD66a,b,c,e-antibody for conditioning of high-risk ALL and CML patients prior to stem cell transplantation | 2000 | 1 |
| 20 | 1994 | 16 |
About Hartmut Doehner
Hartmut Doehner is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Immunology and Public Health, Environmental and Occupational Health, having authored 32 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (572 citations), Public Health, Environmental and Occupational Health (606 citations), Oncology (402 citations) and Molecular Biology (806 citations). Hartmut Doehner has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include David Head, Roel Willemze, Richard A. Larson, John M. Bennett, Bruce D. Cheson, Wolfgang Hiddemann, Elihu H. Estey, Francesco Lo‐Coco, Cheryl L. Willman and Tim Lister. Their work appears in journals such as Blood, Haematologica, Journal of Clinical Oncology, Leukemia Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.